APOE and familial hyperaldosteronism: In FH patients, the decreases seen with the E3 and E4 isoforms were smaller, a fact possibly attributable to the clearance of APOE via LDLR where binding may be impaired due to the high frequency of LDLR gene mutations in FH patients.